Indian stocks: Visit www.stage2stocks.com →

Genenta Science S.p.A.

Stage 4 · Declining · week 4

As of Oct 22, 2026, Genenta Science S.p.A. is in Stage 4, the downtrend phase, now in week 4 (since Sep 29, 2026). It closed at $0.63, 89.8% below its 52-week high and below its 200-day average, which is falling.

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. More about the company

$0.63
-4.55% today
$30.4M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is GNTA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 48w
S2 17w
S4 49w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 48w → S1 7w → S2 17w → S3 8w → S4 10w → S1 7w → S4 49w → S1 7w → S2 5w → S3 5w → S4 3w current
Total tracked: 166 weeks across 11 stage runs.

GNTA among Conglomerates25th of 28 by relative strength

All 28 →
Stocks in Conglomerates ranked by relative strength, with stage and one-month change
#StockStageRS1M
1NNBRStage 2 · wk 2493−13.7%
2RCMTStage 2 · wk 1189−7.0%
3DLXStage 4 · wk 479−0.0%
4PAMStage 4 · wk 377−3.0%
5CODIStage 2 · wk 975−9.1%
6CRESYStage 2 · wk 174−14.2%
7TUSKStage 3 · wk 172−6.8%
8OTTRStage 3 · wk 369+1.8%
…25GNTAStage 4 · wk 411−2.9%
vs 52W High
-89.8%
$0.58 lo$6.20 hi
89.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 4
1w13w26w
Week 4, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-40.7%
200 DMA: $1.06 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.69x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-2.9%
3M
-60.4%
6M
-10.3%
YTD
-55.3%
1Y
-80.9%
Scan Membership
Breakout Watch
Latest: 2024-09-06
2 appearances in last 60 days. First seen: 2023-02-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 4 · Vol 0.69x
2026-10-21S4
Wk 4 · Vol 0.59x
2026-10-20S4
Wk 4 · Vol 0.45x
2026-10-19S4
Wk 3 · Vol 2.46x
2026-10-16S4
Wk 3 · Vol 0.75x
2026-10-15S4
Wk 3 · Vol 0.31x
2026-10-14S4
Wk 3 · Vol 1.66x
2026-10-13S4
Wk 3 · Vol 0.64x
2026-10-12S4
Wk 2 · Vol 0.49x
2026-10-09S4
Wk 2 · Vol 1.16x
2026-10-08S4
Wk 2 · Vol 0.97x
2026-10-07S4
Wk 2 · Vol 0.41x
Moving averages & range
50 DMA
$0.87
200 DMA
$1.06
52W High
$6.20
52W Low
$0.58
5D Low
$0.62
Resistance levels (recent highs)
20d High
$0.80
60d High
$1.51
120d High
$2.20
250d High
$6.20
Next resistance
+27.6%
to 20d High
ROE
-38.0%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 0.6

Genenta Science S.p.A.: quick answers

What stage is Genenta Science S.p.A. in?

As of Oct 22, 2026, Genenta Science S.p.A. (GNTA) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 29, 2026 and is in week 4. What the four stages mean

Is Genenta Science S.p.A. in an uptrend?

No. Genenta Science S.p.A. is in a Stage 4 downtrend. It trades 40.7% below its 200-day average, which is falling.

How far is Genenta Science S.p.A. from its 52-week high?

Genenta Science S.p.A. closed at $0.63 on Oct 22, 2026, 89.8% below its 52-week high of $6.20. Its 52-week low is $0.58.

How has Genenta Science S.p.A. performed over the past year?

As of Oct 22, 2026, Genenta Science S.p.A. is down 80.9% over the past year and down 55.3% so far in 2026.

Which sector and industry is Genenta Science S.p.A. in?

Genenta Science S.p.A. is in the Conglomerates industry, part of the Industrials sector.

About this companyIndustrials· Conglomerates

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.